Skip to main content
Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.920
+0.120 (2.50%)
Dec 20, 2024, 4:00 PM EST - Market closed

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $987.00K in the quarter ending September 30, 2024, with 135.56% growth. This brings the company's revenue in the last twelve months to $2.65M, down -26.49% year-over-year. In the year 2023, Orchestra BioMed Holdings had annual revenue of $2.76M, down -21.88%.

Revenue (ttm)
$2.65M
Revenue Growth
-26.49%
P/S Ratio
67.08
Revenue / Employee
$47,268
Employees
56
Market Cap
187.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.76M-773.00K-21.88%
Dec 31, 20223.53M4.32M-551.79%
Dec 31, 2021-782.00K-6.49M-113.71%
Dec 31, 20205.70M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

OBIO News

More News